Dexcom analysis | Health Updates from Today
In the world of diabetes management, the Dexcom G7 has emerged as an upgrade over its predecessor, the Dexcom G6. This new device offers several improvements that can enhance comfort and glucose management for individuals living with diabetes.
One of the key advantages of the Dexcom G7 is its smaller sensor size. At approximately 60% smaller than the G6, the G7 is less bulky and more comfortable to wear, particularly for active users or those with sensitive skin.
The G7 also boasts greater accuracy, with an 8.2% MARD (Mean Absolute Relative Difference) for adults and 8.1% for children, making it the most accurate CGM on the market today.
Another benefit of the G7 is its streamlined insertion process, which many users find simpler than the G6. The device provides glucose readings every 5 minutes, just like the G6, supporting timely glucose management.
One of the standout features of the G7 is its predictive low alerts. These alerts can help minimise lows and improve A1C outcomes, making it a game-changer for many users. The G7 also integrates with smart devices like Apple Watch and Garmin, facilitating remote monitoring and data sharing with followers.
However, it's important to note that the transition from G6 to G7 may depend on insurance coverage, costs, and individual financial situations. Some users might choose to continue with the G6 if the G7 is not accessible or cost-effective.
Since the G6 is still highly accurate and reliable, some users may not find the improvements critical enough to switch immediately. The sensor life of the G7 is FDA-approved for 10 or 14 days, depending on the region, although usage might vary for users.
The American Diabetes Association recommends a person base their diet on lean ground beef, fresh vegetables and fruit, nuts, and fish containing omega-3, such as salmon, while avoiding foods that are high in salt, sugar, and saturated fat.
Exercise can play an important role in helping a person maintain a moderate weight and manage their blood sugar levels, lowering a person's overall blood sugar levels for up to 24 hours. CGM systems, like Dexcom, can be safe and effective in monitoring blood sugar levels, improving quality of glycemic control, reducing the risk of hypoglycemia, and permitting selection of lower target levels for average glucose and HbA1c.
Before ordering any CGM system, it's crucial to talk with your doctor, as Medicare and insurance require a doctor's prescription. If a person experiences any symptoms that do not match their blood sugar readings, they should contact Dexcom support, as this could be a sign the device is not working correctly.
It's also important to note that Dexcom has received mixed reviews regarding customer service and sensor accuracy, with some users requiring constant calibration. The Better Business Bureau (BBB) gives Dexcom an A- grade, but the company does not hold accreditation with this organization.
In conclusion, the Dexcom G7 offers notable improvements in size, accuracy, and usability, which can improve comfort and glucose management. However, the decision to switch from G6 to G7 should consider personal preferences, financial factors, and discussions with healthcare providers.
- The Dexcom G7 can be monitored using smart devices like Apple Watch and Garmin, supporting health-and-wellness, nutrition, and medical-conditions management by providing real-time data and remote monitoring.
- The Dexcom G7 is an FDA-approved CGM (Continuous Glucose Monitoring) system that is safe and effective in monitoring glucose levels for individuals with diabetes, enhancing overall health-and-wellness and quality of glycemic control.
- Before purchasing any CGM system, it's mandatory to consult with a healthcare provider to ensure proper prescription and insurance coverage under Medicare, as this may influence the choice between models like the Dexcom G6 and G7.
